Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
about
Alzheimer's in 3D culture: challenges and perspectivesAPP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).Alzheimer disease models and human neuropathology: similarities and differences3-N-butylphthalide improves neuronal morphology after chronic cerebral ischemia.Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: digital morphometric analysesTransgenic models of Alzheimer's disease: learning from animalsAnimal models of amyloid-beta-related pathologies in Alzheimer's disease.Astrocyte mediated MMP-9 activation in the synapse dysfunction: An implication in Alzheimer disease.Tau aggregation and its interplay with amyloid-β.Compensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans?Does my mouse have Alzheimer's disease?Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's diseasePlaques, tangles, and memory loss in mouse models of neurodegeneration.Conditionally inducible tau mice--designing a better mouse model of neurodegenerative diseases.Overview on rodent models of Alzheimer's disease.Coexisting cholinergic and parahippocampal degeneration: a key to memory loss in dementia and a challenge for transgenic models?S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice modelImmunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.Murine models of Alzheimer's disease and their use in developing immunotherapies.APP transgenic mice: their use and limitations.Insights into Alzheimer disease pathogenesis from studies in transgenic animal models.EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearanceUnraveling protein misfolding diseases using model systemsMutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux.Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease.Cytoplasmic cytochrome c immunolabelling in dystrophic neurites in Alzheimer's disease.Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.Selective deposition of mutant tau in the FTDP-17 brain affected by the P301L mutation.Immunohistochemical detection of the delayed formation of nonfibrillar large amyloid-β aggregates.Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice.Presenilin 1 and cadherins: stabilization of cell-cell adhesion and proteolysis-dependent regulation of transcription.Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated from yeast deficient in orthologues of glycogen synthase kinase-3beta or cdk5.Fuzhisan, a Chinese herbal medicine, inhibits beta-amyloid-induced neurotoxicity and tau phosphorylation through calpain/Cdk5 pathway in cultured cortical neurons
P2860
Q26801081-04422DFD-FFD8-428B-9F06-B883569E4D81Q30455082-18A82C15-EE0F-43CB-A0A0-9DA15A8081D9Q30499574-8CDDE708-3FC6-4035-A317-FB127ACC153EQ30849684-9FAB75AD-5053-49B0-9C9A-E164887FD5C1Q33202467-F220DE23-C352-4492-BB7D-728952803FA9Q33844718-F11CA0C2-8577-42F6-AE16-43F605116EEBQ34097190-90DF3442-B766-4CF0-A3C0-B0058F474C66Q34907690-886759D6-CA51-4F96-90F1-2A36E52422ABQ35008256-07F79850-B814-4D47-8FAF-FC5A24C69E89Q35153576-421D9347-CDFB-4505-81D5-071EEDC68E51Q35186500-CFDCD1DF-1EF3-453F-8204-CED152047C56Q36196728-7FF29981-0D78-492E-AC55-DF52622E6E9FQ36638038-D8843902-D5A4-4462-8A2F-342373BE54ABQ37053945-3594FF9D-2CD3-46E6-9713-501E8C7AA905Q37144525-8E4D85C8-90F3-4A8B-987F-1CF074B205F0Q37180132-ED5D4F1A-A654-45A0-B5DC-5BE2F0F50940Q37603519-6416089D-F822-4E43-B7C4-C35EB670941EQ37655247-68957CFE-A899-4552-8FBF-850BFBA75433Q37752915-6352D637-0458-41CB-B4E3-E624A75AFBF6Q37820330-A6BE80A7-3A99-4604-AC35-950BF3568566Q37903737-3B87399D-E82A-41AD-9BB8-106478B9E665Q38733357-48E8D398-88BB-4CB9-A80F-247D879D80EBQ38782138-437297C0-595B-4CE6-B3D9-943F13A26CD8Q38970045-8B0FEF18-E923-449F-8FD7-D0991657B9FAQ39891449-C4837915-3782-4F6A-B7CA-369F019F8F3BQ42621245-5C4A78B1-7EA1-4ABA-A910-C520CC9A70F1Q46240917-43F8A95E-92F8-4AD5-9764-BE8C93456A4DQ46918165-86BB5ADB-E6C3-4594-93D0-354DF58ACD5CQ47345806-3429CAFE-D053-4587-B4D3-4F1F73BD402BQ48113034-58D3D7AA-1DC2-49FC-9110-124584464FD9Q48467327-8BE52DC4-8903-47B0-A033-331F9BD3B3A1Q48587989-6CE811BB-AB94-4BCC-8BF2-4F3FF3C84D46Q48793186-9DE9890D-1CE7-4E04-977F-DAA34BE3D84EQ48951871-9BDC9894-5EAE-42BB-A577-8CE538E80AE1Q49136975-47B67123-2E9F-4C57-8F20-29B8113C458CQ50763421-39A686F6-C3F1-4456-B3DA-C32A1DD379A5Q53280053-D25B0E79-9259-4A02-98D9-6F62C71BFB63Q53842029-E5753D1C-8B76-4B66-9F37-19C51E707DFDQ56558091-BC35CF2A-A07C-4E62-995B-17AD414240EC
P2860
Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neurofibrillary pathology in t ...... eta-amyloid precursor protein.
@ast
Neurofibrillary pathology in t ...... eta-amyloid precursor protein.
@en
type
label
Neurofibrillary pathology in t ...... eta-amyloid precursor protein.
@ast
Neurofibrillary pathology in t ...... eta-amyloid precursor protein.
@en
prefLabel
Neurofibrillary pathology in t ...... eta-amyloid precursor protein.
@ast
Neurofibrillary pathology in t ...... eta-amyloid precursor protein.
@en
P2093
P2860
P356
P1476
Neurofibrillary pathology in t ...... eta-amyloid precursor protein.
@en
P2093
P2860
P304
P356
10.1093/JNEN/60.4.357
P577
2001-04-01T00:00:00Z